Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Clinical Data Updates & Treatment Management Strategies in First-line ALK-positive Metastatic Non-Small Cell Lung Cancer(NSCLC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    BOOST - Multiple Myeloma An Oncology Boosting Program
    Release Date:
    Review Process: Expert Review Panel
    Translation:(link)
    Quality Improvement Oncology Netherlands
    PARP-Inhibitor Combination Treatments: Safety and Efficacy in a rapidly changing mCRPC landscape
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Education in the Era of Emerging Hemophilia Therapy
    Release Date:
    Partner: National Bleeding Disorders Foundation
    Review Process: Expert Review Panel
    Education Rare Disease Guam, Puerto Rico, USA
    Education for Patients and Caregivers Living with Bladder Cancer from NMIBC to la/mUC
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    USP <797> Pharmaceutical Compounding-Sterile Preparations: Ensuring Compliance Now and For the Future
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    COVID-19 Burden and Benefit of Vaccination - Global excluding US, Canada and Taiwan
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines All
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    2024 Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
    Release Date:
    Partner: Global Bridges at Mayo Clinic
    Review Process: Expert Review Panel
    Quality Improvement Rare Disease All
    Junior Investigator Global ATTR Cardiac Amyloidosis Research
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease Australia, Canada, France, Germany, Italy, Japan, Korea, Spain
    Reducing Barriers to Optimal Clinical Care in Breast Cancer
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology Spain
    Quality Improvement Grants to Improve Identification and Management of Patients with ATTR Amyloidosis
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease Spain
    Advances in Migraine Management
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    2024 IM US Headache Medicine Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Internal Medicine USA
    RSV Infection and RSV Maternal Immunization in Area of Obstetrics and Gynecology
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Education Vaccines Japan
    Transthyretin Cardiac Amyloidosis Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Rare Disease USA
    Increasing Awareness and Understanding of Amyloid Transthyretin Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Advancing The Use of Oral Anticoagulants in Atrial Fibrillation and Venous Thromboembolism
    Release Date:
    Partner: Bristol Myers Squibb
    Review Process: Pfizer Internal
    Education Internal Medicine All
    Bolstering Clinical Research Capacity to Address China Health Equity Disparities
    Release Date:
    Review Process: Pfizer Internal
    Education Health Equity China
    Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease USA